Genmab — Juni 2019
-
Genmab/Sydbank: Janssen-aftale synliggør Genmab er andet end Darzalex"- Aftalen understreger det gode samarbejde med Janssen, blåstempler Genmabs teknologi-pipeline og synliggør, at selskabet er andet end bare Darzalex - og det er noget af det, der skal drive værdiansættelsen fra det nuværende niveau, siger han.
- Aftaler som denne her - data fra midler i den kliniske udviklings-pipeline - kan synliggøre nogle af de værdier, som kan gemme sig i pipelinen" Godt Søren:-)
-
J&J takes option on Genmab follow-up to Darzalex
Blockbuster partners look to next chapter - while takeover talk persists -
http://www.pmlive.com/pharma_news/j_and_j_takes_option_on_genmab_follow-up_to_darzalex_1290498 -
Fra artiklen i pmlive.com, som EL linkede til: "..With analysts nevertheless predicting that peak sales could reach upwards of $5bn a year.."
-
det er investorer der bringer det rygte op omkring opkøb fra jansen. Det kommer ikke til at ske
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
